Personal Human lmmune System Mice: Accelerating the Translation of lmmuno-therapies from Bench to Bedside

Register Link:

https://www.eventbrite.com/e/genobiotx-february-2025-webinar-tickets-1228646116609?aff=oddtdtcreator

Date:

  • Wednesday, Feb. 26th, 2025; 2:00 pm EST or 11:00 am PST

Meet Our Speaker:

Dr. Huang earned a Ph.D. in 2004 from the Institute of Zoology, Chinese Academy of Sciences, followed by a postdoctoral fellowship at Peking University Health Science Center (2004–2006). Dr. Huang has dedicated over 15 years to groundbreaking research in the United States at prestigious institutions, including Albert Einstein College of Medicine, the Aaron Diamond AIDS Research Center, Rockefeller University, and Columbia University. A member of Sigma Xi, the Genetics Society of America, and the American Geriatrics Society, Dr. Huang has authored more than 30 peer-reviewed papers in esteemed journals such as Science Translational Medicine and Frontiers in Immunology. Their research focuses on tumor immunology, vaccines, infectious diseases, and animal model development. In 2019, Dr. Huang] founded Genomab Biotech (www.genomab.com) in New York, where they serve as CEO. In 2021, they further expanded their vision by establishing NexVivo Biotech in Suzhou, China, advancing innovation in the biotech industry globally.

About GenoBioTX

GenoBioTX provides comprehensive animal modeling services, ranging from model construction to preclinical in vitro and in vivo assays, based on the combination of versatile technical platforms and experienced scientist.

Contact us

Website: www.genobiotx.com
Email: info@genobiotx.com
Address: 10410 Corporate Dr., Sugar Land, TX, 77478, USA

Watch Video

    News Center

    2024.11.01

    These Mice Are About to Go Viral Because of the Nobel Prize!

    The 2024 Nobel Prize in Physiology or Medicine has been announced, and the winners are two American scientists, Victor Ambros and Gary Ruvkun, in recognition of their discovery of microRNA and its role in post-transcriptional gene regulation. This discovery is considered a major breakthrough following the central dogma of molecular biology. The Nobel Committee stated […]

    2024.11.01

    Webinar on Advances in Antibody-Drug Conjugates (ADCs) Development & Preclinical Models

    Join our webinar on June 26th to explore the development and preclinical evaluation of Antibody-Drug Conjugates (ADCs), focusing on their components, mechanisms, and the selection of effective preclinical models for advancing targeted cancer therapies. Date: · Wednesday, June 26th, 2024; 2:00 pm EDT or 11:00 am PDT Webinar Highlights: Understand the components and mechanisms of […]

    Email Back to top